Aneid Produtos Farmaceuticos Lda.
www.aneid.ptFounded in 1997, Aneid Produtos Farmacêuticos Lda. (Aneid) is focused on marketing “niche” Class I medical devices and food supplements positioned as adjunct nutritional products. Aneid´s operating philosophy is the future of the pharmaceutical industry will be driven by: a) reduction in government drug reimbursement due to financial budgetary restraints. b) greater reliance on generic pharmaceuticals; and c) greater reliance on the use of genetic screening devices to determine “proclivities” or probability of future disease, leading to a reliance on dietary recommendations by doctors as opposed to prescriptions for synthetics pharmaceuticals. With this philosophy in mind, Aneid Lda has focused on “niche” products that have clinical support or require specialized training. Product History Late 1990´s Launched Modafinil (Modiodal) for narcolepsy-licensed from Lafon Laboratories Ltd. Launched Gelclair for oral mucositis due to radiotherapy-licensed from Sinclair Pharmaceuticals Ltd. Launched SST for dry mouth due to Xerotomia-licensed from Sinclair Pharmaceuticals Ltd. Launched Kineiso Tape (neuromuscular tape) for use by physiotherapists in Portugal, Spain and Italy. (First European distributor for Kinesio). 2000-2020 Launched Corpet (Coriolus versicolor biomass) for veterinary use in Portugal and Spain-licensed from Mycology Research Laboratories Ltd. Launched Coriolus-MRL (Coriolus versicolor biomass) for chronic fatigue syndrome- licensed from Mycology Research Laboratories Ltd. Launched Cordyceps-MRL (Cordyceps sinensis biomass) for alcohol induced liver steatosis-licensed from Mycology Research Laboratories Ltd. Launched Isoflavones-MRL for pre-menopause and menopause. Launched Intest Aid IB for celiac disease in children and adults licensed from Neucleotide Nutrition Ltd.
Read moreFounded in 1997, Aneid Produtos Farmacêuticos Lda. (Aneid) is focused on marketing “niche” Class I medical devices and food supplements positioned as adjunct nutritional products. Aneid´s operating philosophy is the future of the pharmaceutical industry will be driven by: a) reduction in government drug reimbursement due to financial budgetary restraints. b) greater reliance on generic pharmaceuticals; and c) greater reliance on the use of genetic screening devices to determine “proclivities” or probability of future disease, leading to a reliance on dietary recommendations by doctors as opposed to prescriptions for synthetics pharmaceuticals. With this philosophy in mind, Aneid Lda has focused on “niche” products that have clinical support or require specialized training. Product History Late 1990´s Launched Modafinil (Modiodal) for narcolepsy-licensed from Lafon Laboratories Ltd. Launched Gelclair for oral mucositis due to radiotherapy-licensed from Sinclair Pharmaceuticals Ltd. Launched SST for dry mouth due to Xerotomia-licensed from Sinclair Pharmaceuticals Ltd. Launched Kineiso Tape (neuromuscular tape) for use by physiotherapists in Portugal, Spain and Italy. (First European distributor for Kinesio). 2000-2020 Launched Corpet (Coriolus versicolor biomass) for veterinary use in Portugal and Spain-licensed from Mycology Research Laboratories Ltd. Launched Coriolus-MRL (Coriolus versicolor biomass) for chronic fatigue syndrome- licensed from Mycology Research Laboratories Ltd. Launched Cordyceps-MRL (Cordyceps sinensis biomass) for alcohol induced liver steatosis-licensed from Mycology Research Laboratories Ltd. Launched Isoflavones-MRL for pre-menopause and menopause. Launched Intest Aid IB for celiac disease in children and adults licensed from Neucleotide Nutrition Ltd.
Read moreCountry
City (Headquarters)
Cascais
Industry
Employees
11-50
Founded
1997
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Founder and Managing Director
Email ****** @****.comPhone (***) ****-****
Technologies
(22)